Oasis urges competitive privatization process for Kobayashi Pharmaceutical

Kobayashi Pharmaceutical's largest shareholder Oasis is urging that the company's privatization process be competitive, as the health products maker considers a buyout offer said to exceed $3.2 billion.

Detected & updated continuously · Source: Nebula